Identification and validation of the miRNA–mRNA regulatory network in fetoplacental arterial endothelial cells of gestational diabetes mellitus

References

• Artzi NS, Shilo S, Hadar E, et al. Prediction of gestational diabetes based on nationwide electronic health records. Nat Med. 2020;26(1):71–76. .
   PubMed Web of Science ®Google Scholar
• Ejdesjö A, Wentzel P, Eriksson UJ. Influence of maternal metabolism and parental genetics on fetal maldevelopment in diabetic rat pregnancy. Am J Physiol Endocrinol Metab. 2012;302(10):E1198–209.
   PubMed Web of Science ®Google Scholar
• Basu M, Garg V. Maternal hyperglycemia and fetal cardiac development: clinical impact and underlying mechanisms. Birth Defects Res. 2018;110(20):1504–1516.
   PubMed Web of Science ®Google Scholar
• Brett KE, Ferraro Z, Yockell-Lelievre J, et al. Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta. Int J Mol Sci. 2014;15(9):16153–16185. .
   PubMed Web of Science ®Google Scholar
• Sobrevia L, Salsoso R, Fuenzalida B, et al. Insulin is a key modulator of fetoplacental endothelium metabolic disturbances in gestational diabetes mellitus. Front Physiol. 2016;7:119.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Jauniaux E. Development of the Human Placenta and Fetal Heart: synergic or Independent? Front Physiol. 2018;9(p):373.
   PubMed Web of Science ®Google Scholar
• Steurer MA, Peyvandi S, Baer RJ, et al. Impaired fetal environment and gestational age: what is driving mortality in neonates with critical congenital heart disease? J Am Heart Assoc. 2019;8(22):e013194. .
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Chang G, Mouillet J-F, Mishima T, et al. Expression and trafficking of placental microRNAs at the feto-maternal interface. Faseb J. 2017;31(7):2760–2770. .
   PubMed Web of Science ®Google Scholar
• Lorenzo-Almorós A, Hang T, Peiró C, et al. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):140
   Google Scholar
• Shi R, Zhao L, Cai W, et al. Maternal exosomes in diabetes contribute to the cardiac development deficiency. Biochem Biophys Res Commun. 2017;483(1):602–608. .
   PubMed Web of Science ®Google Scholar
• Radhakrishna U, Albayrak S, Zafra R, et al. Placental epigenetics for evaluation of fetal congenital heart defects: ventricular septal defect (VSD). PLoS One. 2019;14(3):e0200229. .
   PubMed Web of Science ®Google Scholar
• Strutz J, Cvitic S, Hackl H, et al. Gestational diabetes alters microRNA signatures in human feto-placental endothelial cells depending on fetal sex. Clin Sci (Lond). 2018;132(22):2437–2449. .
   PubMed Web of Science ®Google Scholar
• Cvitic S, Novakovic B, Gordon L, et al. Human fetoplacental arterial and venous endothelial cells are differentially programmed by gestational diabetes mellitus, resulting in cell-specific barrier function changes. Diabetologia. 2018;61(11):2398–2411. .
   PubMed Web of Science ®Google Scholar
• Lu L, Townsend KA, Daigle BJ Jr. GEOlimma: differential expression analysis and feature selection using pre-existing microarray data. BMC Bioinformatics. 2021;22(1):44.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. .
   PubMed Web of Science ®Google Scholar
• Zhang M, Dong Y, Hu F, et al. Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes. Nat Immunol. 2018;19(3):279–290. .
   PubMed Web of Science ®Google Scholar
• Dweep H, Sticht C, Pandey P, et al. miRWalk--database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform. 2011;44(5):839–847. .
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Database):D561–8. .
   PubMed Web of Science ®Google Scholar
• Lou W, Chen J, Ding B, et al. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. J Transl Med. 2018;16(1):266. .
   PubMed Web of Science ®Google Scholar
• He MY, Wang G, Han -S-S, et al. Negative impact of hyperglycaemia on mouse alveolar development. Cell Cycle. 2018;17(1):80–91. .
   PubMed Web of Science ®Google Scholar
• Si ZP, Wang G, Han -S-S, et al. CNTF and Nrf2 are coordinately involved in regulating self-renewal and differentiation of neural stem cell during embryonic development. iScience. 2019;19:303–315.
   PubMed Web of Science ®Google Scholar
• Han SS, Wang G, Jin Y, et al. Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy. PLoS One. 2015;10(9):e0139141. .
   PubMed Web of Science ®Google Scholar
• Depla AL, De Wit L, Steenhuis TJ, et al. Effects of maternal diabetes on fetal heart function at echocardiography: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57(4):539–550
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang L, Yu J, et al. Alteration of the microRNA expression profile and identification of miRNA/mRNA negative regulation pairs in neural tube defects. Acta Biochim Biophys Sin (Shanghai). 2019;51(7):761–765. .
   PubMed Web of Science ®Google Scholar
• Wommack JC, Trzeciakowski JP, Miranda RC, et al. Micro RNA clusters in maternal plasma are associated with preterm birth and infant outcomes. PLoS One. 2018;13(6):e0199029. .
   PubMed Web of Science ®Google Scholar
• Vonkova B, Blahakova I, Hruban L, et al. MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163(3):259–264. .
   PubMed Web of Science ®Google Scholar
• Hromadnikova I, Kotlabova K, Dvorakova L, et al. Substantially altered expression profile of diabetes/cardiovascular/cerebrovascular disease associated micrornas in children descending from pregnancy complicated by gestational diabetes mellitus-one of several possible reasons for an increased cardiovascular risk. Cells. 2020;9:6
   Web of Science ®Google Scholar
• Aryan L, Medzikovic L, Umar S, et al. Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs. Biol Sex Differ. 2020;11(1):14. .
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhao D. MicroRNA-362-5p promotes the proliferation and inhibits apoptosis of trophoblast cells via targeting glutathione-disulfide reductase. Bioengineered. 2021;12(1):2410–2419.
   PubMed Web of Science ®Google Scholar
• Bishop SP, Zhou Y, Nakada Y, et al. Changes in cardiomyocyte cell cycle and hypertrophic growth during fetal to adult in mammals. J Am Heart Assoc. 2021;10(2):e017839. .
   PubMed Web of Science ®Google Scholar
• Mohamed TMA, Ang Y-S, Radzinsky E, et al. Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell. 2018;173(1):104–116. . e12
   PubMed Web of Science ®Google Scholar
• Boogerd CJ, Zhu X, Aneas I, et al. Tbx20 is required in mid-gestation cardiomyocytes and plays a central role in atrial development. Circ Res. 2018;123(4):428–442. .
   PubMed Web of Science ®Google Scholar
• Recamonde-Mendoza M, Werhli AV, Biolo A. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy. Gene. 2019;698:157–169.
   PubMed Web of Science ®Google Scholar
• Marques FZ, Vizi D, Khammy O, et al. The transcardiac gradient of cardio-microRNAs in the failing heart. Eur J Heart Fail. 2016;18(8):1000–1008. .
   PubMed Web of Science ®Google Scholar
• Kameny RJ, He Y, Zhu T, et al. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease. Am J Physiol Heart Circ Physiol. 2018;315(4):H847–h854. .
   PubMed Web of Science ®Google Scholar
• Chetaille P, Preuss C, Burkhard S, et al. Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm. Nat Genet. 2014;46(11):1245–1249. .
   PubMed Web of Science ®Google Scholar
• Kolwicz SC Jr., Odom GL, Nowakowski SG, et al. AAV6-mediated cardiac-specific overexpression of ribonucleotide reductase enhances myocardial contractility. Mol Ther. 2016;24(2):240–250. .
   PubMed Web of Science ®Google Scholar
• Ganss R. Keeping the balance right: regulator of g protein signaling 5 in vascular physiology and pathology. Prog Mol Biol Transl Sci. 2015;133:93–121.
   PubMed Web of Science ®Google Scholar
• Harris IS, Treskov I, Rowley MW, et al. G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes. 2004;53(12):3082–3090. .
   PubMed Web of Science ®Google Scholar
• Li H, He C, Feng J, et al. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci U S A. 2010;107(31):13818–13823. .
   PubMed Web of Science ®Google Scholar
• Wakil SM, Ram R, Muiya NP, et al. A genome-wide association study reveals susceptibility loci for myocardial infarction/coronary artery disease in Saudi Arabs. Atherosclerosis. 2016;245:62–70.
   PubMed Web of Science ®Google Scholar
• Hahn J, Fu Y-P, Brown MR, et al. Genetic loci associated with prevalent and incident myocardial infarction and coronary heart disease in the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. PLoS One. 2020;15(11):e0230035. .
   PubMed Web of Science ®Google Scholar
• Wang Y, Du X, Zhou Z, et al. A gain-of-function ACTC1 3ʹUTR mutation that introduces a miR-139-5p target site may be associated with a dominant familial atrial septal defect. Sci Rep. 2016;6:25404.
   PubMed Web of Science ®Google Scholar
• Wang L, Qin D, Shi H, et al. MiR-195-5p promotes cardiomyocyte hypertrophy by targeting MFN2 and FBXW7. Biomed Res Int. 2019;2019:1580982
   PubMed Web of Science ®Google Scholar
• McGregor M, Hariharan N, Joyo A, et al. CENP-A is essential for cardiac progenitor cell proliferation. Cell Cycle. 2014;13(5):739–748. .
   PubMed Web of Science ®Google Scholar
• Teng L, Huang Y, Guo J, et al. Cardiac fibroblast miR-27a may function as an endogenous anti-fibrotic by negatively regulating early growth response protein 3 (EGR3). J Cell Mol Med. 2021;25(1):73–83. .
   PubMed Web of Science ®Google Scholar
• Ramakrishna S, Kim I-M, Petrovic V, et al. Myocardium defects and ventricular hypoplasia in mice homozygous null for the Forkhead Box M1 transcription factor. Dev Dyn. 2007;236(4):1000–1013. .
   PubMed Web of Science ®Google Scholar
• Li X, Wei C, Zhang Z, et al. MiR-134-5p regulates myocardial apoptosis and angiogenesis by directly targeting KDM2A after myocardial infarction. Int Heart J. 2020;61(4):815–821. .
   PubMed Web of Science ®Google Scholar
• Lu M, Qin X, Yao J, et al. MiR-134-5p targeting XIAP modulates oxidative stress and apoptosis in cardiomyocytes under hypoxia/reperfusion-induced injury. IUBMB Life. 2020;72(10):2154–2166. .
   PubMed Web of Science ®Google Scholar